← Oncology Approval Tracker

FDA DECISION ·

Bortezomib for Injection (Hospira)

bortezomib · Hospira

FDA approvalNew formulationMultiple myeloma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

An additional bortezomib-for-injection product approved for use in adults with multiple myeloma.

LAMPGEN ANALYSIS

Why it matters

This approval concerns a specific injectable product for an existing myeloma treatment.

What research teams should watch

Use the product-specific reconstitution, route and handling instructions when incorporating it into an order set.

PRIMARY RECORDS

Sources